Did On-Site Rapid DNA Testing Identify al-Baghdadi’s Remains?

Over the past few years, several companies have developed rapid DNA tests that can be used in the field to identify remains in 90 minutes—but President Trump suggested the confirmation only took 15.

Written byEmma Yasinski
| 3 min read
Abu Bakr al-Baghdadi rapid dna ande thermo fisher

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: President Trump announcing the death of Abu Bakr al-Baghdadi on October 27, 2019
FLICKR, THE WHITE HOUSE

On Sunday (October 27), President Donald Trump announced that US Special Operations forces had cornered Abu Bakr al-Baghdadi, the current leader of the Islamic State. After such a high-profile raid, it was crucial to confirm that the man who had detonated a suicide vest, killing himself and several children, was indeed the target.

In the announcement, Trump said that “part of the genius” of those who carried out the raid was that they brought lab technicians and a previously acquired sample of Baghdadi’s DNA to conduct an “on-site test” to confirm that they had killed the right man. He went on to say, “It was a very quick call that took place about 15 minutes after he was killed and it was positive. It was ‘this is a confirmation, sir.’”

Some have taken ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies